Pharmaceutical Exhaust Treatment: Wet Scrubber Design Guide

Pharmaceutical Exhaust Treatment: Wet Scrubber Design Guide

A pharmaceutical plant’s exhaust system must handle three chemically distinct streams — solvent VOCs from synthesis reactors, acid gases from halogenation reactions, and API-laden dust from fluid bed dryers — each requiring a different scrubber chemistry and configuration. Generic scrubber designs that work for steel pickling or chemical manufacturing will fail in pharmaceutical service because they do not account for batch concentration variability, GMP-compliant materials, and solvent-specific solubility limits. This pharmaceutical exhaust treatment guide covers the regulatory framework (FDA cGMP, EPA MACT, OSHA PELs), exhaust characterization methodology, per-solvent scrubber design parameters for the four most common pharmaceutical solvents, acid gas and mixed-stream scrubber design, FBD exhaust and CIP system design, GMP-compliant construction requirements, and performance monitoring protocols. The focus is on packed bed and venturi scrubber technologies for pharmaceutical applications, with specific design data that enables facility engineers and EHS managers to specify the correct system for their exhaust profile.

Key Takeaways

• Each pharmaceutical solvent requires a different L/G ratio and pH — designing for generic “solvent VOC” guarantees failure. Methanol needs L/G 10-20 at neutral pH, acetone needs pH 6-7 to avoid forming diacetone alcohol, and ethyl acetate needs L/G 15-25 with a decanter because its solubility is limited to 80 g/L. Packing depth must be 6 to 14 feet depending on the solvent.
• A batch reactor’s peak VOC concentration is 5 to 15 times the average — the scrubber must be sized for the peak, not the average. A 100 ppm average with a 500 ppm peak requires a scrubber with a turndown ratio of 10:1 on the caustic feed system and a PID or FID at the outlet for solvent breakthrough detection during the peak period.
• FRP is not acceptable for GMP pharmaceutical scrubbers — 316L SS with electropolished surfaces is the only FDA-compliant option. 316L SS costs $80-150/ft² but passes FDA inspection. PP at $20-40/ft² is acceptable only for non-GMP areas. The IQ/OQ documentation package must include material certifications, weld records, and surface finish reports.
• A condenser-scrubber combination pays for itself in 12 to 24 months at facilities using more than 50,000 liters of solvent per year. The condenser recovers 60 to 80 percent of the solvent as reusable liquid when concentrations exceed 5,000 ppm. The scrubber treats the remaining 20 to 40 percent, reducing operating costs by 40 to 60 percent.
• Continuous parametric monitoring of pH, ΔP, and flow rate at 15-minute intervals is required for EPA MACT compliance, with 5-year data retention. Any excursion lasting more than 4 hours must be reported to the EPA. A PID at the scrubber outlet provides early warning of solvent breakthrough during batch peak periods.

Regulatory Framework for Pharmaceutical Exhaust

Pharmaceutical exhaust scrubbers must comply with three overlapping regulatory frameworks that affect the design, operation, and documentation of the system. The FDA cGMP requirements under 21 CFR Part 211 govern the construction materials, cleanability, and validation of any equipment that contacts pharmaceutical manufacturing areas — including the exhaust system. The EPA National Emission Standards for Hazardous Air Pollutants (NESHAP) under 40 CFR Part 63 Subpart GGG establish emission limits for hazardous air pollutants. The OSHA permissible exposure limits under 29 CFR 1910.94 set workplace exposure limits.

FDA cGMP requirements for exhaust systems. The FDA cGMP regulations require that all equipment used in pharmaceutical manufacturing be of appropriate construction material to prevent contamination of the drug product. For exhaust systems, this means the scrubber must not shed particles or fibers into the exhaust stream. FRP scrubbers are not acceptable where the exhaust stream could be drawn into the pharmaceutical manufacturing area through a negative pressure differential. 316L stainless steel with electropolished surfaces is the preferred material for pharmaceutical exhaust scrubbers in GMP-classified areas. The scrubber must be drainable without liquid holdup, accessible for cleaning and inspection, and constructed with continuously welded joints rather than flanged connections where possible. The cGMP validation requirement means the scrubber must undergo installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) before being placed into service. The IQ documents that the scrubber was installed per the manufacturer’s specifications. The OQ documents that all instrumentation — pH probe, flow meter, ΔP transmitter — operates within its specified range. The PQ documents that the scrubber achieves the required removal efficiency for the target pharmaceutical pollutants. The three qualification documents must be maintained for the life of the equipment and made available during FDA inspections.

EPA MACT standards for pharmaceutical manufacturing. The EPA MACT standards for pharmaceutical manufacturing under 40 CFR Part 63 Subpart GGG apply to facilities that manufacture pharmaceutical products through chemical synthesis, fermentation, or biological processing. The standards establish emission limits for organic HAPs (hazardous air pollutants) and inorganic HAPs from process vents, storage vessels, and wastewater operations. The emission limit for organic HAPs from process vents is 20 ppmv or 98 percent reduction by weight. The limit for HCl is 4 ppmv or 95 percent reduction. A wet scrubber used to comply with MACT standards must demonstrate continuous compliance through parametric monitoring — the scrubber inlet and outlet pH, recirculation flow rate, and pressure drop must be recorded and maintained within the ranges established during the PQ. Parametric monitoring data must be retained for 5 years per EPA record-keeping requirements.

OSHA exposure limits for pharmaceutical emissions. OSHA established permissible exposure limits for the most common pharmaceutical emissions: methanol 200 ppm TWA, acetone 250 ppm TWA, ethyl acetate 400 ppm TWA, isopropyl alcohol 400 ppm TWA, HCl 5 ppm ceiling, and HBr 3 ppm TWA. The scrubber must maintain outlet concentrations below these limits at the stack discharge point. OSHA 29 CFR 1910.94 requires that all exhaust systems serving hazardous processes maintain design airflow at all times and be inspected at least annually. The daily scrubber logs — pH, ΔP, flow rate — serve double duty as both scrubber operating records and OSHA compliance documentation. A scrubber that fails to maintain its design parameters must be repaired before the associated pharmaceutical process can resume operation.

Pharmaceutical Exhaust Characterization

Before any scrubber can be designed, the pharmaceutical exhaust treatment system requires characterization of the exhaust streams by flow rate, concentration profile, temperature, and particulate loading. The characterization methodology is the same regardless of whether the exhaust comes from a single reactor vent or a combined header serving multiple process vessels. The key data required for each exhaust stream includes the normal flow rate and the peak flow rate, the normal concentration and the peak concentration, the solvent composition as a percentage of the total VOC load, the exhaust temperature range, and the presence of any acid gases or particulate.

Solvent VOC exhaust profiles. Pharmaceutical solvent VOC exhaust is characterized by batch cycle variability that is fundamentally different from continuous chemical process exhaust. A single batch reactor may produce zero VOC emissions during the heating phase, peak VOC emissions of 200 to 500 ppm during the solvent reflux or distillation phase, and then return to near-zero during the cooling and discharge phase. The batch cycle time is typically 8 to 24 hours, and the peak VOC emission period lasts 1 to 4 hours. The peak-to-average concentration ratio for a batch reactor vent is typically 5:1 to 15:1. This means a scrubber designed for the average concentration of 100 ppm will see peak concentrations of 500 to 1,500 ppm during the solvent distillation phase. The scrubber must maintain removal efficiency during these peaks because the peak concentration period often coincides with the maximum allowable emission rate under the facility’s air permit. The caustic feed system must be designed for a turndown ratio of at least 10:1 — a variable-speed dosing pump controlled by a pH controller with a wide proportional band that prevents over-dosing during zero-emission periods and responds quickly during peak emission periods.

Fume hood and pilot plant exhaust. Laboratory fume hoods and pilot plant exhaust systems typically handle multiple small streams combined into a single exhaust header. The total flow rate is 2,000 to 15,000 CFM depending on the number of hoods and the facility layout. The VOC concentration in combined fume hood exhaust is typically 10 to 50 ppm — much lower than reactor vent concentrations — but the exhaust volume is continuous and the composition changes unpredictably as different hoods are used for different experiments. The scrubber for fume hood exhaust must handle a wide range of solvent types at low concentrations. A packed bed scrubber with water recirculation at L/G 10 to 15 gpm/1,000 CFM is typically sufficient for fume hood exhaust because the low concentration means the scrubber operates well below the solvent solubility limit. However, the scrubber must include a pH control system with both acid and caustic feed because the hood exhaust may contain either acid gases or alkaline gases depending on the experiments being conducted. A dual-feed pH controller with a setpoint of pH 7 ±1 provides the flexibility to handle both acid and alkaline excursions without operator intervention.

Acid gas and FBD exhaust characterization. Acid gas exhaust from pharmaceutical synthesis typically has HCl or HBr at 50 to 200 ppm during reaction periods with zero emissions between batches. FBD exhaust has a continuous flow of 1,000 to 5,000 CFM with API dust at 5 to 50 mg/Nm³ and moisture content above 80 percent relative humidity at 40 to 70°C. The high moisture content means the FBD exhaust scrubber must be designed for water condensation in the ductwork — the duct must be sloped to a drain point and insulated to prevent condensation corrosion. The FBD exhaust temperature of 40 to 70°C is within the range of standard PP scrubbers (rated to 80°C), but the high moisture content requires the scrubber to be designed with a larger sump volume to accommodate the condensate added to the recirculation liquid during operation.

Solvent VOC Scrubber Design Parameters

Each pharmaceutical solvent has a different water solubility, optimal scrubber pH, and required liquid-to-gas ratio. A pharmaceutical exhaust treatment system designed for generic “solvent VOC” without specifying the individual solvent composition will result in a system that may achieve 90 percent removal for methanol but only 40 percent for ethyl acetate. The four most common pharmaceutical solvents — methanol, acetone, ethyl acetate, and isopropyl alcohol — require different operating parameters that must be incorporated into the scrubber design specification. The table below provides the design parameters for each solvent at 20°C scrubber liquid temperature and ambient exhaust temperature.

Methanol and isopropyl alcohol. Methanol is completely miscible with water and requires no pH adjustment for removal. The scrubber recirculation can be plain water at L/G 10 to 20 gpm/1,000 CFM with a packing depth of 6 to 10 feet of 2-inch polypropylene random packing. Methanol removal efficiency above 99 percent is achievable at an L/G of 15 gpm/1,000 CFM. Isopropyl alcohol has similar design parameters to methanol because it is also completely miscible with water. The same L/G range of 10 to 20 gpm/1,000 CFM with neutral water recirculation achieves above 98 percent removal. Both methanol and IPA have high vapor pressures that require the scrubber outlet temperature to be maintained below 30°C to prevent evaporation of the absorbed solvent from the recirculation liquid back into the gas stream. A scrubber operating at 35 to 40°C sump temperature will have 5 to 15 percent lower methanol removal efficiency than the same scrubber operating at 25°C.

Acetone. Acetone requires pH control that differs from the other common pharmaceutical solvents. Acetone reacts with sodium hydroxide to form diacetone alcohol and other condensation products. Diacetone alcohol has a higher boiling point than acetone and accumulates in the recirculation liquid, where it increases the biochemical oxygen demand of the scrubber blowdown. The scrubber pH must be maintained at 6 to 7 using water or a mildly acidic recirculation. Hydrochloric acid or sulfuric acid is added to the recirculation tank to neutralize any caustic carryover from the caustic scrubber stage if the acetone scrubber is the second stage of a two-stage system. The L/G ratio for acetone is 10 to 15 gpm/1,000 CFM with a packing depth of 8 to 12 feet. Acetone removal efficiency is above 95 percent at an L/G of 12 gpm/1,000 CFM but drops to 85 to 90 percent if the pH rises above 9.

Ethyl acetate. Ethyl acetate has the lowest water solubility of the four common solvents at 80 g/L at 20°C. Above this concentration, ethyl acetate forms a separate organic phase that floats on the surface of the recirculation water. The scrubber must be designed with a decanter or a continuous skimming system to remove the organic layer before it accumulates and affects the recirculation pump performance. The L/G ratio for ethyl acetate is 15 to 25 gpm/1,000 CFM — higher than the other solvents because the lower solubility requires more water to absorb the same mass of solvent. The removal efficiency for ethyl acetate at L/G 20 gpm/1,000 CFM is 85 to 95 percent. Above 25 gpm/1,000 CFM, the marginal improvement in removal efficiency diminishes and the increased pumping cost outweighs the benefit. A packed depth of 10 to 14 feet is required because ethyl acetate is a slower-absorbing compound than methanol or IPA.

Solvent recovery with condenser prescrubber. When the solvent concentration in the reactor vent exceeds 5,000 ppm during the distillation phase, installing a condenser ahead of the scrubber recovers 60 to 80 percent of the solvent as reusable liquid. The condenser is a shell-and-tube heat exchanger chilled to 0 to 10°C using plant chilled water or a dedicated glycol chiller. The condensed solvent is collected in a receiver and returned to the solvent storage tank for reuse. The remaining 20 to 40 percent of the solvent that is not condensed passes through to the scrubber for removal. The scrubber is sized for the post-condenser load, which is 50 to 70 percent lower than the raw vent load. A condenser-scrubber combination at a facility using more than 50,000 liters of solvent per year typically pays for itself in 12 to 24 months through recovered solvent value, and it reduces the scrubber operating cost by 40 to 60 percent because the lower solvent load requires less recirculation flow and fewer packing stages.

Acid Gas and Mixed-Stream Scrubber Design

Acid gases from pharmaceutical operations — HCl from chlorination reactions, HBr from bromination, and SO₂ from sulfonation — are removed in packed bed scrubbers with caustic recirculation. The pharmaceutical exhaust treatment system for acid gases operates at pH 8 to 10. The design of an acid gas scrubber for pharmaceutical service is straightforward from a chemistry perspective because HCl and HBr are highly soluble in water and react rapidly with sodium hydroxide. The removal efficiency for all three acid gases in a properly designed caustic scrubber is above 99 percent at an L/G ratio of 5 to 10 gpm/1,000 CFM with a packing depth of 3 to 6 feet. The design challenge is not the removal chemistry but the batch variability — the acid gas concentration can vary from 0 to 500 ppm within a single batch cycle, and the caustic feed system must respond without over-dosing or under-dosing.

The caustic feed pump for a pharma acid gas scrubber should be a variable-speed diaphragm pump controlled by a PID pH controller with a proportional band of 2 pH units (the controller output goes from 0 to 100 percent as the pH varies from 7 to 9). The solenoid-operated bleed valve should be interlocked with the caustic feed pump — when the caustic feed pump runs, the bleed valve opens at a fixed blowdown rate to prevent salt accumulation. The pH controller should have a pH sensor redundancy with two independent pH probes and automatic sensor validation. If the primary and secondary pH probe readings differ by more than 0.5 pH units, the controller alarms and switches to the probe with the reading closest to the setpoint. This prevents a single probe drift event from causing a caustic over-feed or under-feed that results in an acid breakthrough.

Two-stage design for mixed halogenated-solvent streams. When the exhaust stream contains both acid gases and solvent VOCs — for example, HCl from a chlorination reaction and methanol from a methanolysis step in the same reactor — a single-stage scrubber cannot achieve optimal removal for both pollutant classes because the optimal pH for acid gas removal (pH 8 to 10) causes acetone to form diacetone alcohol and reduces methanol removal efficiency by evaporative loss at elevated pH. The recommended configuration is a two-stage scrubber: Stage 1 operating at pH 8 to 10 with caustic recirculation for acid gas removal, followed by Stage 2 operating at pH 6 to 7 with water recirculation for VOC removal. The two stages are in series with separate recirculation tanks, pumps, and pH controllers. Stage 1 removes the acid gases at above 99 percent efficiency. The gas then passes to Stage 2, where the VOCs are removed at the per-solvent efficiencies listed in the solvent design table. The two-stage system adds 30 to 50 percent to the capital cost compared to a single-stage system but achieves 10 to 15 percent higher overall removal efficiency for mixed streams.

Material selection for mixed acid-solvent service. The material of construction for a pharma acid gas scrubber must be compatible with both the acid gas and any entrained solvent. Polypropylene is suitable for HCl and HBr service at concentrations below 20 percent and temperatures below 80°C. For exhaust streams that contain both HCl and acetone, or HCl and ethyl acetate, the PP may be attacked by the solvent component at elevated temperatures. For mixed streams, 316L stainless steel is the safe choice even though the acid gas is corrosive to 316L SS at high concentrations — the scrubbing liquid pH of 8 to 10 in Stage 1 neutralizes the acid before it contacts the vessel wall, and the Stage 2 pH of 6 to 7 with high water flow rate keeps the chloride concentration below 500 ppm in the recirculation liquid, which is within the corrosion resistance limit for 316L SS at temperatures below 50°C.

FBD Exhaust and CIP System Design

Fluid bed dryer exhaust is the most mechanically challenging stream in any pharmaceutical exhaust treatment system. The scrubber design must account for all three characteristics simultaneously. The FBD exhaust scrubber is typically a two-stage system: a venturi prescrubber for particulate removal followed by a packed bed for gas absorption.

Venturi prescrubber for API dust. The venturi prescrubber is a converging-diverging section that accelerates the FBD exhaust to 200 to 400 ft/s at the throat. Scrubbing liquid is injected at the throat at 15 to 30 gpm/1,000 CFM and atomized into fine droplets by the high-velocity gas stream. The droplets collide with API dust particles and capture them, achieving 95 to 99 percent removal efficiency for particles above 1 micron. The pressure drop across the venturi section is 20 to 40 in. W.G., which requires the scrubber fan to be sized for the additional static pressure. The venturi prescrubber has no packing and no moving parts, making it the most reliable option for FBD exhaust service where API dust loading can vary from 5 to 50 mg/Nm³ depending on the product being dried. The spent scrubbing liquid from the venturi section contains the captured API dust. This liquid must be treated as hazardous waste because it contains active pharmaceutical ingredients at concentrations of 100 to 1,000 mg/L depending on the product and the liquid-to-solid ratio. The hazardous waste disposal cost adds 15 to 30 percent to the total scrubber operating cost compared to a non-API scrubber treating the same gas volume. The waste must be collected in a dedicated tank, characterized per RCRA requirements, and shipped to a permitted hazardous waste treatment facility.

Clean-in-place system design. The CIP system is required for pharmaceutical scrubbers to enable cleaning between product changeovers. When the facility switches from manufacturing one API product to another, the scrubber must be cleaned to prevent cross-contamination of the exhaust stream. The CIP system consists of a CIP supply pump, a CIP solution tank, and a minimum of 4 spray nozzles positioned inside the scrubber to reach all internal surfaces — the packing surface, the mist eliminator, the vessel walls, and the sump. The CIP cycle circulates cleaning solvent at 60 to 80°C for 30 to 60 minutes. The cleaning solvent is typically water for water-soluble APIs, or a dilute caustic solution at pH 10 to 11 for APIs that are not water-soluble. After the cleaning cycle, the CIP solution is drained to the hazardous waste tank, and the scrubber is rinsed with clean water for 15 to 30 minutes. The rinse water is also sent to the hazardous waste tank if the API concentration in the rinse water exceeds 1 mg/L. The CIP system adds $15,000 to $40,000 to the scrubber capital cost depending on the CIP tank size and the number of spray nozzles.

Changeover and campaign management. The scrubber campaign schedule must be coordinated with the production campaign schedule. When a new API campaign starts, the scrubber recirculation liquid should be fresh water or fresh caustic solution to prevent cross-contamination from the previous campaign. The blowdown rate during the first 24 hours of a new campaign should be increased to 2 to 3 times the normal blowdown rate to flush any residual API from the previous campaign out of the system. The scrubber outlet concentration should be monitored with a photoionization detector or a flame ionization detector during the first hour of the new campaign to verify that no solvent breakthrough occurs due to the change in solvent composition. If the outlet concentration exceeds 50 percent of the permitted emission limit, the scrubber operating parameters — L/G ratio, pH, and caustic concentration — should be adjusted and re-verified.

GMP-Compliant Scrubber Construction

The construction materials and fabrication methods for a pharmaceutical exhaust treatment system determine whether the system passes FDA inspection. A scrubber built with the wrong materials or with unacceptably rough internal surfaces can cause a Form 483 observation or a warning letter during an FDA inspection, which delays the product launch and requires expensive retrofits. Three material options are available for pharmaceutical scrubber construction, each with specific applications and limitations.

316L stainless steel with electropolished surfaces. 316L SS is the preferred material for pharmaceutical scrubbers in GMP-classified areas. The 316L grade has low carbon content (maximum 0.03 percent) that prevents carbide precipitation during welding, maintaining the corrosion resistance at the weld joint. The internal surfaces must be electropolished to a surface finish of Ra 0.5 microns or better to prevent particle accumulation and facilitate cleaning. All internal welds must be fully penetrated, ground smooth, and passivated. The weld joints must be continuously welded — no skip welding or stitch welding is permitted. The vessel must be designed with sloped bottoms (minimum 5 degrees from horizontal) and fully drainable piping to prevent liquid holdup. 316L SS scrubbers cost $80 to $150 per ft² of vessel surface area, making them the most expensive option, but they are the only option that passes FDA inspection without documentation exceptions.

Polypropylene for non-GMP areas. Polypropylene scrubbers are acceptable for pharmaceutical exhaust streams that do not come into contact with GMP-classified manufacturing areas — for example, a scrubber treating acid gas from a waste solvent tank vent that is located outside the manufacturing building. PP has adequate chemical resistance for HCl, HBr, and caustic service at concentrations below 20 percent and temperatures below 80°C. PP scrubbers cost $20 to $40 per ft². The PP vessel must be fabricated with continuously extruded sheet and triple-pass welding for all seams. The internal surfaces of a PP scrubber cannot be electropolished to the same surface finish as 316L SS, so PP is not acceptable for scrubbers located inside GMP-classified areas where the exhaust stream could be drawn back into the manufacturing environment.

FRP is not acceptable for GMP pharmaceutical service. FRP scrubbers shed glass fibers from the corrosion barrier under normal operating conditions. The glass fibers are carried in the exhaust stream and can settle in the ductwork or be released to the atmosphere. In a GMP-classified facility, glass fibers in the exhaust stream represent a contamination risk that is unacceptable to FDA inspectors. FRP is acceptable for pharmaceutical scrubbers only when the scrubber is located outside the manufacturing building and the exhaust stream does not return to the building through any pathway.

Documentation and IQ/OQ validation. The scrubber manufacturer must provide a complete documentation package that includes: material certifications with mill test reports for all 316L SS components, welding procedure specifications and welder qualification records, surface finish measurement reports for electropolished surfaces, hydrostatic test reports, and instrument calibration certificates for all pH probes, flow meters, and pressure transmitters. The IQ is performed after installation and documents that the scrubber was installed per the P&ID and that all utility connections are correct. The OQ is performed with water recirculation and documents that all instruments operate within their specified ranges, that the recirculation pump delivers the design flow rate at the design pressure, and that there are no leaks in the recirculation piping. The OQ also documents the CIP system operation by verifying that all spray nozzles reach the intended internal surfaces using a riboflavin spray pattern test. The IQ/OQ documentation package must be retained for the life of the equipment and made available during FDA inspections.

Monitoring and Compliance

A pharmaceutical exhaust treatment system must be monitored continuously to demonstrate compliance with the EPA MACT emission limits. The monitoring system includes continuous measurement of the scrubber operating parameters, periodic verification of the emission concentration, and a data recording system that retains the monitoring data for the required retention period.

Continuous emission monitoring requirements. The EPA MACT standards require parametric monitoring for scrubbers used to comply with the 20 ppmv organic HAP limit and the 4 ppmv HCl limit. The parameters that must be monitored continuously are the scrubber recirculation pH (monitored with a redundant pH probe system), the scrubber pressure drop (monitored with a differential pressure transmitter with high and low alarms), the recirculation flow rate (monitored with a flow meter with a low-flow alarm), and the caustic feed tank level (monitored with a level transmitter with a low-level alarm). The monitoring data must be recorded at a minimum frequency of once per 15 minutes and retained for 5 years. The pH probe must be verified against a handheld meter weekly, and the verification must be recorded in the scrubber log with the as-found and as-left readings. Any monitoring excursion — a pH reading below 7.5, a pressure drop above 120 percent of the baseline established during the PQ, a recirculation flow rate below 90 percent of design — must be documented with the time of the excursion, the corrective action taken, and the time the parameter returned to the normal range. An excursion that lasts more than 4 hours triggers a requirement to report the excursion to the EPA as a deviation from the MACT standard.

Solvent breakthrough detection. Solvent breakthrough occurs when the scrubber packing becomes saturated with absorbed solvent or when the recirculation liquid reaches its equilibrium concentration for the target solvent. The earliest sign of breakthrough is a rising outlet VOC concentration measured by a photoionization detector (PID) or a flame ionization detector (FID) installed at the scrubber outlet. The PID is calibrated to the primary solvent in the exhaust stream and set to alarm at 50 percent of the permitted emission limit. A PID reading that rises above the baseline by more than 20 percent during a batch cycle indicates that the recirculation liquid is approaching saturation and the blowdown rate should be increased. A PID reading that rises above 80 percent of the permit limit requires immediate corrective action — increase the recirculation flow rate, increase the blowdown rate to reduce the dissolved solvent concentration, or reduce the process gas flow if the solvent load exceeds the scrubber design capacity. Solvent breakthrough is most common during the peak emission period of a batch cycle (the solvent distillation phase) when the scrubber is operating at its maximum design capacity. A scrubber that experiences regular solvent breakthrough during peak emission periods needs a higher L/G ratio, a deeper packed bed, or a condenser prescrubber to reduce the peak solvent load.

pH control for batch variability. The pH control system for a pharmaceutical scrubber must handle the batch variability that is unique to pharmaceutical manufacturing. The caustic feed pump should be a variable-speed diaphragm pump with a turndown ratio of 10:1 — capable of delivering 100 percent flow at design conditions and 10 percent flow during low-load periods. The pH controller should have a proportional band of 2 to 3 pH units to prevent oscillation between over-feed and under-feed. The controller should also have a feed-forward input from the batch process control system when available — a signal from the reactor control system that indicates the start of the solvent distillation phase allows the pH controller to increase the caustic feed rate in anticipation of the acid gas load, rather than waiting for the pH to drop before responding. A feed-forward pH control system reduces the peak pH excursion during batch transitions by 50 to 70 percent compared to a feedback-only system.

Pharmaceutical Exhaust Treatment FAQ

What is the best scrubber for pharmaceutical solvent VOC removal?
A packed bed scrubber with water recirculation at L/G 10 to 25 gpm/1,000 CFM is the standard pharmaceutical exhaust treatment approach. Methanol and IPA require L/G 10-20. Acetone requires pH 6-7. Ethyl acetate requires L/G 15-25 plus a decanter for phase separation. The packing depth should be 6 to 14 feet depending on the solvent and target removal efficiency.

What GMP materials are required for a pharmaceutical scrubber?
316L stainless steel with electropolished surfaces (Ra 0.5 microns or better) is the preferred material for scrubbers in GMP-classified areas. PP is acceptable for non-GMP areas such as waste tank vents located outside the manufacturing building. FRP is not acceptable for GMP service because it sheds glass fibers.

How does batch variability affect scrubber design?
Batch reactors produce VOC concentrations that vary from 0 to 500 ppm within a single cycle. The scrubber must handle a peak-to-average concentration ratio of 5:1 to 15:1. The caustic feed system needs a turndown ratio of 10:1. Feed-forward pH control from the batch control system reduces pH excursions by 50 to 70 percent.

What is a condenser-scrubber combination and when is it used?
A condenser installed ahead of the scrubber recovers 60 to 80 percent of the solvent as reusable liquid when the vent concentration exceeds 5,000 ppm during distillation. The remaining 20 to 40 percent passes to the scrubber. The payback period for a condenser-scrubber combination is 12 to 24 months at facilities using more than 50,000 liters of solvent per year.

What monitoring is required for MACT compliance?
Continuous monitoring of recirculation pH, pressure drop, and recirculation flow rate with data recording every 15 minutes and 5-year retention. A PID or FID at the scrubber outlet for solvent breakthrough detection. Weekly pH probe verification against a handheld meter with documentation.

How is a pharmaceutical scrubber cleaned between product changeovers?
A CIP system circulates cleaning solvent or water at 60 to 80°C for 30 to 60 minutes through spray nozzles positioned to reach all internal surfaces. The CIP solution and rinse water are sent to hazardous waste. The blowdown rate should be increased during the first 24 hours of a new campaign to flush residual API.

Conclusion: Design for the Batch, Not the Average

The most common mistake in pharmaceutical exhaust treatment is designing the scrubber for the average VOC concentration instead of the peak batch concentration. A scrubber that is sized for the average of 100 ppm will be overloaded during the 500 ppm peak, violating the air permit and exposing the facility to EPA enforcement action. The design must start with the batch emission profile — the peak concentration, the peak duration, and the solvent composition during the peak — and the scrubber must be sized to maintain the required removal efficiency at the peak condition. GMP-compliant construction materials, a well-designed CIP system, and continuous emission monitoring complete the pharmaceutical scrubber system. For a design review of your pharmaceutical exhaust treatment requirements, contact our applications engineering team at sales@xichengep.com or visit the Air Emissions contact page. For detailed scrubber sizing calculations, refer to our packed bed scrubber design guide.